Sonnet Biotherapeutics Holdings Inc (SONN) — Long-term Investment Intensity
Sonnet Biotherapeutics Holdings Inc (SONN) has a Long-term Investment Intensity of 1.2% as of March 2020. Long-term investments of $389.60K represent 1.2% of total assets of $31.32 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check cash flow reinvestment rate of Sonnet Biotherapeutics Holdings Inc to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Sonnet Biotherapeutics Holdings Inc Long-term Investment Intensity (2013–2016)
This chart shows how Sonnet Biotherapeutics Holdings Inc's Long-term Investment Intensity has evolved across 4 annual periods from 2013 to 2016. As of March 2020, the intensity stands at 1.2%, reflecting long-term investments of $389.60K against total assets of $31.32 Million USD. Explore how well can Sonnet Biotherapeutics Holdings Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Sonnet Biotherapeutics Holdings Inc (2013–2016)
The table below presents the year-by-year Long-term Investment Intensity for Sonnet Biotherapeutics Holdings Inc from 2013 to 2016, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Sonnet Biotherapeutics Holdings Inc market capitalisation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2016 | 2.4% | $800.00K | $33.49 Million | ▼ -0.2 pp |
| 2015 | 2.6% | $1.08 Million | $42.21 Million | ▼ -1.9 pp |
| 2015 | 4.4% | $1.59 Million | $35.79 Million | ▼ -8.0 pp |
| 2013 | 12.4% | $2.49 Million | $20.09 Million | — |